circADAMTS12 Inhibits the Antitumor Activity of Microglia to Enable Metastatic Colonization in the Brain

Zhengmiao Xia1,2,3, Weiguang Liu4, Danni Guo1

  • 1Department of Biochemistry, School of Life Sciences, Nanjing Normal University, Nanjing, China.

Cancer Research
|September 12, 2025
PubMed

Insights

Circular RNA circADAMTS12 promotes breast cancer brain metastasis by suppressing microglia immunity. Targeting circADAMTS12 and PD-L1 inhibits tumor growth, offering potential new therapeutic strategies.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Breast-to-brain metastasis is a lethal complication of breast cancer with limited treatment options.
  • Microglia are key immune cells that normally suppress tumor growth and metastasis.
  • Understanding how cancer cells evade microglia is crucial for developing new therapies.

Purpose of the Study:

  • To investigate the molecular mechanisms by which breast cancer cells evade microglia-mediated immunity in the brain.
  • To identify potential therapeutic targets for inhibiting breast cancer brain metastasis.

Main Methods:

  • Analysis of circular RNA circADAMTS12 expression in cancer cells.
  • Assessment of microglia polarization and PD-L1 expression.
  • Evaluation of therapeutic strategies targeting circADAMTS12 and PD-L1 in mouse models.

Main Results:

  • Increased circADAMTS12 expression in cancer cells suppressed microglia antitumor activity.
  • circADAMTS12 induced M2-like microglia polarization and upregulated PD-L1.
  • Targeting circADAMTS12 and PD-L1 effectively suppressed brain metastasis in mouse models.

Conclusions:

  • circADAMTS12 promotes breast cancer brain metastasis by suppressing microglia-mediated antitumor immunity.
  • circADAMTS12 and PD-L1 are potential therapeutic targets for breast cancer brain metastasis.
  • Combined targeting of circADAMTS12 and PD-L1 shows synergistic effects in blocking brain metastasis.